Stanford researchers have found that malignant breast cancer cells can extend protrusions known as invadopodia to dig escape tunnels through surrounding tissue, revealing a possible new target for therapies.
Learn more about all that Stanford ChEM-H and Baker Family Co-Director Carolyn Bertozzi are doing to connect basic scientists, engineers, and clinicians to advance human health.
The Stanford scientists will receive $32 million over five years to fund explorations of cancer, the brain, the aging process, chromosomes and the development of cells.
As chemist Carolyn Bertozzi takes on a new role as Baker Family Co-Director, Stanford ChEM-H, she talks about bridging gaps between chemistry research and medical practice and preparing graduate students for the future.
Seventeen Stanford faculty are part of new Bay Area-wide collaborative research teams funded by the Chan Zuckerberg Biohub, co-directed by Stephen Quake.
For us, figuring out how hard something is requires only a simple touch. From the stiff surface of a stone to the fluffy delight of snow – we effortlessly measure objects’ tautness every day. But for scientists, figuring out the mechanical properties of an object, such as how stiff or soft...
Identification of the human skeletal stem cell by Stanford scientists could pave the way for regenerative treatments for bone fractures, arthritis and joint injuries.
Two graduate students and their respective advisers, ChEM-H faculty fellows Christina Smolke and John Boothroyd, were awarded grants for scientific leadership and dedication to diversity and inclusion in the sciences.
Stanford scientists have shown that cellulose serves a mortar-like role to enhance the adhesion of bacteria to bladder cells, causing urinary tract infections.
This summer, five graduate students from the University of Puerto Rico had the opportunity to use SLAC’s world-class facilities to keep their studies on track.
A molecule called propionate inhibits the growth of Salmonella in mice and may be a promising new treatment for people sickened by the pathogen, according to a new Stanford study.
Stanford researchers have joined forces to learn how immune cells in some kidney transplant patients fight a common virus. The work could lead to a test to predict who is at risk, and possibly develop new treatments.
Boosting efforts to fight antibiotic resistance, Stanford researchers have found that a thin membrane, thought to be just a shrink wrap around some bacterial cell walls, has structural properties critical for survival. Drugs that destroy the membrane could be a new approach to treating infection.
Scientists at Stanford used the wire to capture free-floating tumor cells in the blood, a technique that soon could be used in humans to yield an earlier cancer diagnosis.
Fanconi anemia is a rare but deadly disease, and there are no good drugs to treat its root cause. Now, Stanford researchers are developing a test that could help kids with the disease and millions more with related conditions.
Stanford researchers used genetic-editing tools and stem cell technology to uncover whether a genetic mutation linked to a heart rhythm disorder was benign or pathogenic.